EU Awards $5.3M to Consortium Developing RNAi Screening Methods | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cytoo will coordinate a project announced on Monday that aims to combine high-throughput applications of RNAi with Cytoo's new cell normalization technology.

As part of the project, being funded with €4 million ($5.3 million) over three years under the European Commission's Seventh Framework Programme, Cytoo will partner with Cenix BioScience, Bioquant/Heidelberg University, École Polytechnique Fédérale de Lausanne, and Institute FTMC.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.